Core Laboratories N.V. (CLB)
NYSE: CLB · IEX Real-Time Price · USD
17.07
+0.54 (3.27%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Core Laboratories Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 15.12 | 15.43 | 17.7 | 13.81 | 11.09 | 13.12 | 14.4 | 14.76 | 22.49 | 23.35 | Upgrade
|
| Cash & Cash Equivalents | 15.12 | 15.43 | 17.7 | 13.81 | 11.09 | 13.12 | 14.4 | 14.76 | 22.49 | 23.35 | Upgrade
|
| Cash Growth | -2.00% | -12.85% | 28.23% | 24.47% | -15.43% | -8.92% | -2.47% | -34.36% | -3.67% | -6.93% | Upgrade
|
| Receivables | 109.35 | 106.91 | 96.83 | 83.19 | 131.58 | 129.16 | 133.1 | 114.33 | 145.69 | 197.16 | Upgrade
|
| Inventory | 71.7 | 60.45 | 45.44 | 38.15 | 50.16 | 45.66 | 33.32 | 33.72 | 40.91 | 43.37 | Upgrade
|
| Other Current Assets | 26.96 | 28.92 | 29.08 | 30.7 | 28.4 | 43.04 | 26.61 | 23.65 | 29.46 | 37.94 | Upgrade
|
| Total Current Assets | 223.14 | 211.7 | 189.06 | 165.85 | 221.24 | 230.98 | 207.43 | 186.46 | 238.55 | 301.82 | Upgrade
|
| Property, Plant & Equipment | 153.47 | 157.41 | 172.34 | 181.68 | 199.2 | 122.92 | 123.1 | 129.88 | 143.21 | 149.01 | Upgrade
|
| Goodwill and Intangibles | 106.37 | 106.93 | 107.58 | 108.03 | 230.88 | 232.47 | 188.44 | 188.98 | 188.2 | 175.11 | Upgrade
|
| Other Long-Term Assets | 103.42 | 102.32 | 111.88 | 113.03 | 123.36 | 62.47 | 65.85 | 67.73 | 55.3 | 47.39 | Upgrade
|
| Total Long-Term Assets | 363.26 | 366.65 | 391.8 | 402.73 | 553.44 | 417.85 | 377.39 | 386.59 | 386.71 | 371.51 | Upgrade
|
| Total Assets | 586.4 | 578.35 | 580.85 | 568.58 | 774.67 | 648.83 | 584.81 | 573.05 | 625.26 | 673.33 | Upgrade
|
| Accounts Payable | 33.51 | 45.85 | 29.73 | 23.03 | 35.61 | 41.16 | 41.7 | 33.72 | 33.47 | 47.08 | Upgrade
|
| Deferred Revenue | 4.76 | 5.94 | 7.77 | 5.46 | 13.38 | 17.33 | 17.07 | 15.69 | 14.1 | 11.01 | Upgrade
|
| Current Debt | 10.18 | 11.7 | 12.34 | 11.44 | 11.84 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Liabilities | 39.66 | 39.65 | 40.95 | 49.83 | 50.76 | 44.07 | 41.81 | 54.61 | 73.18 | 73.77 | Upgrade
|
| Total Current Liabilities | 88.1 | 103.14 | 90.78 | 89.75 | 111.59 | 102.55 | 100.58 | 104.02 | 120.76 | 131.87 | Upgrade
|
| Long-Term Debt | 205.21 | 210.69 | 237.92 | 315.54 | 369.94 | 289.77 | 226.99 | 216.49 | 430.99 | 353.67 | Upgrade
|
| Other Long-Term Liabilities | 63.28 | 75.57 | 91.15 | 87.72 | 111 | 95.61 | 108.52 | 97.24 | 97.21 | 93.79 | Upgrade
|
| Total Long-Term Liabilities | 268.49 | 286.27 | 329.07 | 403.26 | 480.94 | 385.38 | 335.5 | 313.73 | 528.2 | 447.47 | Upgrade
|
| Total Liabilities | 356.59 | 389.4 | 419.85 | 493.01 | 592.53 | 487.93 | 436.08 | 417.76 | 648.96 | 579.33 | Upgrade
|
| Total Debt | 215.39 | 222.39 | 250.26 | 326.98 | 381.78 | 289.77 | 226.99 | 216.49 | 430.99 | 353.67 | Upgrade
|
| Debt Growth | -3.15% | -11.14% | -23.46% | -14.36% | 31.75% | 27.66% | 4.85% | -49.77% | 21.86% | 32.46% | Upgrade
|
| Retained Earnings | 120.76 | 85.95 | 68.35 | 50.46 | 160.54 | 156.13 | 173.86 | 187.96 | 219.21 | 415.91 | Upgrade
|
| Comprehensive Income | -4.97 | -3.78 | -10.13 | -7.2 | -6.33 | -5.46 | -8.35 | -9.83 | -10.54 | -11.89 | Upgrade
|
| Shareholders' Equity | 224.82 | 184.26 | 156.45 | 71.51 | 177.87 | 156.76 | 144.84 | 151.35 | -29.06 | 87.57 | Upgrade
|
| Net Cash / Debt | -200.27 | -206.96 | -232.56 | -313.17 | -370.69 | -276.65 | -212.59 | -201.72 | -408.49 | -330.32 | Upgrade
|
| Net Cash Per Share | -4.21 | -4.42 | -4.98 | -7.04 | -8.30 | -6.22 | -4.80 | -4.62 | -9.52 | -7.41 | Upgrade
|
| Working Capital | 135.04 | 108.57 | 98.27 | 76.1 | 109.64 | 128.43 | 106.85 | 82.44 | 117.79 | 169.95 | Upgrade
|
| Book Value Per Share | 4.82 | 3.98 | 3.40 | 1.61 | 4.01 | 3.55 | 3.28 | 3.48 | -0.68 | 1.97 | Upgrade
|